Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL11578306 | 1.00 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL5084707 | 1.00 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL20958140 | 1.00 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL1881649 | 1.00 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL1878023 | 1.00 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL475463 | 1.00 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL5665434 | 0.98 | TSHR (0.76) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL5666383 | 0.98 | TSHR (0.76) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Ethylene Glycol SCHEMBL2437033 | 0.97 | TSHR (0.75) | TSHRALDH1A1LMNAHSD17B10MEN1 | |
| Propanol SCHEMBL11193775 | 0.95 | TSHR (0.80) | TSHRALDH1A1LMNAHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1594440-B1 | THE SELECTIVE AND SPECIFIC PREPARATION OF DISCRETE PEG COMPOUNDS | QUANTA BIODESIGN LTD (US) | 2019-07-03 | — | — | EP | disclosed |
| US-8637711-B2 | Selective and specific preparation of discrete PEG compounds | QUANTA BIODESIGN, LTD. (US) | 2014-01-28 | — | — | US | disclosed |
| US-20110124844-A1 | Selective and Specific Preparation of Discrete Peg Compounds | AUDAX PRIVATE DEBT LLC, AS AGENT | 2011-05-26 | — | — | US | disclosed |
| US-7888536-B2 | Selective and specific preparation of discrete PEG compounds | QUANTA BIODESIGN, LTD. (US) | 2011-02-15 | — | — | US | disclosed |
| EP-1594440-A4 | THE SELECTIVE AND SPECIFIC PREPARATION OF DISCRETE PEG COMPOUNDS | QUANTA BIODESIGN LTD (US) | 2006-12-27 | — | — | EP | disclosed |
| US-20060020134-A1 | Selective and specific preparation of discrete peg compounds | AUDAX PRIVATE DEBT LLC, AS AGENT | 2006-01-26 | — | — | US | disclosed |
| EP-1594440-A2 | THE SELECTIVE AND SPECIFIC PREPARATION OF DISCRETE PEG COMPOUNDS | Quanta Biodesign, Ltd. (US) | 2005-11-16 | — | — | EP | disclosed |
| WO-2004073620-A2 | THE SELECTIVE AND SPECIFIC PREPARATION OF DISCRETE PEG COMPOUNDS | QUANTA BIODESIGN, LTD (US) | 2004-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124844-A1 | Selective and Specific Preparation of Discrete Peg Compounds | PARG, GNE, PAM | TSHR 3935/4885ALDH1A1 1674/4885LMNA 1964/4885 |
| US-20060020134-A1 | Selective and specific preparation of discrete peg compounds | PARG, GNE, PAM | TSHR 3935/4885ALDH1A1 1674/4885LMNA 1964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.